| View |
|
DRP-10658
|
Salbutamol (as sulfate) + Guaifenesin
|
Bronchomed
|
1mg / 50 mg per 5 mL
|
Syrup
|
-
|
San Marino Laboratories Corp.
|
Philippines
|
-
|
03 November 2021
|
15 July 2025
|
| View |
|
DRP-7359-06
|
Spironolactone
|
Spaira
|
25mg
|
Tablet
|
Diuretic
|
Maxtar Bio-Genics
|
India
|
Automatic Renewal
|
02 November 2021
|
04 October 2026
|
| View |
|
DRP-9863
|
Letrozole
|
Letero
|
2.5 mg
|
Film-Coated Tablet
|
Antineoplastic
|
Hetero Labs Limited (Unit-VI)
|
India
|
-
|
30 January 2022
|
16 April 2027
|
| View |
|
DR-XY40913
|
Ascorbic Acid + Zinc Ascorbate
|
Procee Plus
|
97.50 mg/9.0 mg per 5 mL
|
Syrup
|
Vitamins
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
07 January 2022
|
17 January 2027
|
| View |
|
HRP-443
|
Oral Rehydration Salts
|
Hydrite
|
Formulation Per liter (equivalent to 5 sachets) contains: Sodium Potassium Chloride Citrate Glucose
75 mmol 20 mmol 68 mmol 10 mmol 75 mmol
Each sachet contains: Sodium Chloride Trisodium Citrate Dehydrate Potassium Chloride Glucose, Anhydrous
520 mg 580 mg 300 mg 2.7 g
|
Granules for Solution (Apple Flavor)
|
Electrolyte Replenisher
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
03 January 2022
|
24 January 2027
|
| View |
|
DRP-11090
|
Febuxostat
|
Febuton
|
80 mg
|
Film-Coated Tablet
|
-
|
Standard Chem. & Pharm. Co., Ltd.
|
Taiwan
|
-
|
30 January 2022
|
01 June 2026
|
| View |
|
DRP-11088
|
Atomoxetine (as hydrochloride)
|
Attentrol 40
|
40 mg
|
Capsule
|
Psychostimulant (Centrally Acting Sympathomimetic)
|
Sun Pharmaceutical Industries Limited
|
India
|
Automatic Renewal
|
30 January 2022
|
07 January 2027
|
| View |
|
DRP-11089
|
Atomoxetine (as hydrochloride)
|
Attentrol 25
|
25 mg
|
Capsule
|
Psychostimulant (Centrally Acting Sympathomimetic)
|
Sun Pharmaceutical Industries Limited
|
India
|
Automatic Renewal
|
30 January 2022
|
07 January 2027
|
| View |
|
DRP-2288-04
|
Simvastatin
|
None
|
40 mg
|
Tablet
|
Antihyperlipidaemic Agent
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
22 September 2022
|
28 June 2028
|
| View |
|
DRP-2807-06
|
Pioglitazone Hydrochloride
|
Pio-Source
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
01 March 2024
|
22 February 2029
|
| View |
|
DRP-2992-05
|
Colchicine
|
Unbranded
|
500 mcg
|
Tablet
|
Antigout
|
Inga Laboratories P. Ltd
|
India
|
Renewal
|
07 April 2024
|
02 August 2029
|
| View |
|
DRP-4790-02
|
Telmisartan
|
Merit
|
80 mg
|
Tablet
|
Angiotensin-II-Receptor Blocker
|
Cadila Pharmaceuticals Limited
|
India
|
Renewal
|
11 February 2023
|
04 October 2028
|
| View |
|
DRP-4931-01
|
Quetiapine (as fumarate)
|
Quetafarm
|
50 mg
|
Film-Coated Tablet
|
Antipsychotics
|
Sydler Remedies Pvt. Ltd.
|
India
|
Renewal
|
02 July 2023
|
18 November 2028
|
| View |
|
DRP-4948-12
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazorife
|
4 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
Renewal
|
14 March 2023
|
22 November 2028
|
| View |
|
DRP-6621-02
|
Pantoprazole (as sodium)
|
None
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Brawn Laboratories Limited
|
India
|
-
|
28 January 2022
|
06 April 2026
|
| View |
|
DRP-9724-01
|
Iron + Multivitamins
|
Ferix BC
|
(see reverse formulation)
|
Capsule
|
Vitamin/Mineral
|
Lejal Laboratories Inc.
|
Philippines
|
Renewal
|
20 June 2022
|
18 July 2027
|
| View |
|
DRP-10088-01
|
Nicardipine Hydrochloride
|
Argen
|
1 mg/mL
|
Solution for IV Infusion
|
CALCIUM CHANNEL BLOCKER
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
-
|
28 January 2022
|
15 May 2025
|
| View |
|
DRP-10512-03
|
Febuxostat
|
Lesurix 40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
28 January 2022
|
07 October 2026
|
| View |
|
DRP-844-07
|
Simvastatin
|
None
|
20 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
-
|
26 January 2022
|
05 August 2026
|
| View |
|
DRP-4164-31
|
Cefuroxime (as Axetil)
|
Cefutreve
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Brawn Laboratories Limited
|
India
|
Renewal
|
04 April 2022
|
27 December 2027
|